, Tracking Stock Market Picks
Enter Symbol:
Cubist Pharmaceuticals, Inc. (CBST) [hlAlert]

up 430.08 %

Cubist Pharmaceuticals, Inc. (CBST) rated Buy with price target $34 by Stanford Research

Posted on: Wednesday,  Jul 2, 2008  12:25 PM ET by Stanford Research

Stanford Research rated Buy Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) on 07/02/2008. Previously Stanford Research rated Buy Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) on
01/24/2008., when the stock price was $19.11. Since then, Cubist Pharmaceuticals, Inc. has gained 430.09% as of 01/16/2015's recent price of $101.30.
If you would have followed the previous Stanford Research's recommendation on CBST, you would have gained 430.08% of your investment in 2549 days.

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN, the first antibiotic in a new class of antiinfectives called lipopeptides. The Cubist product pipeline includes our lipopeptide program and our natural products screening program. Cubist is headquartered in Lexington, MA.

Stanford Research encompasses both institutional equity research and Washington-focused policy research, offering a perspective on individual companies, sector-specific topics and national policy. The importance Stanford Group Company places on research comes from years of experience in a constantly changing world. We know that as markets develop and new sectors grow, it is imperative that our clients have the most accurate information available to ensure financial success. Stanford Group Company clients will always have our commitment to conduct informative and enlightening research. As a part of our commitment to our clients, we provide objective, well-developed research. Our skilled analysts use their talent to provide invaluable research that can help in making important decisions. Thanks to a wide range of resources obtained through technology, experience and reputation, our research analysts develop reports on the most current firms and sectors. Our equity analysts offer insight and opinions on companies in the consumer/retail, media, energy, financial institutions, health care, technology and water/environment sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/2/2008 12:25 PM Buy
19.08 34.00
as of 12/24/2008
1 Week down  -9.54 %
1 Month down  -0.12 %
3 Months down  -27.16 %
1 YTD down  -33.31 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/24/2008 11:25 AM Buy
19.11 31.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy